Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Joseph

Showing results (241-250 of 267) with videos related to

Pageof 27
Sort By:
The American Journal of Pathology|August 16, 2020
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased MortalityEric Salazar, Paul A Christensen, Edward A Graviss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivationDavid Christie, James Denham, Allison Steigler, et al.
Cancer Causes & Control : CCC|February 20, 2022
Physical activity and glioma: a case-control study with follow-up for survivalZohreh Basiri, Yi Yang, Fiona J Bruinsma, et al.
The American Journal of Pathology|November 6, 2020
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgGEric Salazar, Paul A Christensen, Edward A Graviss, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegansJoon-Hee Lee, Sun-Hye Choi, Oh-Seung Kwon, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical TrialsJohn Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Communications Biology|June 9, 2021
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacyPottayil G Sasikumar, Naremaddepalli S Sudarshan, Srinivas Adurthi, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|June 28, 2024
Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and SafetyLew Lim, Nazanin Hosseinkhah, Mark Van Buskirk, et al.
Neuro-Oncology|December 21, 2022
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26Karen Alpen, Claire M Vajdic, Robert J MacInnis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2015
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trialJames W Denham, Allison Steigler, David Joseph, et al.
Pageof 27

Showing results (241-250 of 267) with videos related to

Sort By:
Pageof 27
The American Journal of Pathology|August 16, 2020
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased MortalityEric Salazar, Paul A Christensen, Edward A Graviss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivationDavid Christie, James Denham, Allison Steigler, et al.
Cancer Causes & Control : CCC|February 20, 2022
Physical activity and glioma: a case-control study with follow-up for survivalZohreh Basiri, Yi Yang, Fiona J Bruinsma, et al.
The American Journal of Pathology|November 6, 2020
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgGEric Salazar, Paul A Christensen, Edward A Graviss, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegansJoon-Hee Lee, Sun-Hye Choi, Oh-Seung Kwon, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical TrialsJohn Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Communications Biology|June 9, 2021
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacyPottayil G Sasikumar, Naremaddepalli S Sudarshan, Srinivas Adurthi, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|June 28, 2024
Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and SafetyLew Lim, Nazanin Hosseinkhah, Mark Van Buskirk, et al.
Neuro-Oncology|December 21, 2022
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26Karen Alpen, Claire M Vajdic, Robert J MacInnis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2015
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trialJames W Denham, Allison Steigler, David Joseph, et al.
Pageof 27